» Articles » PMID: 21840487

ROCK and JAK1 Signaling Cooperate to Control Actomyosin Contractility in Tumor Cells and Stroma

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2011 Aug 16
PMID 21840487
Citations 218
Authors
Affiliations
Soon will be listed here.
Abstract

Proinflammatory cytokines are frequently observed in the tumor microenvironment, and chronic inflammation is involved in cancer initiation and progression. We show that cytokine signaling through the receptor subunit GP130-IL6ST and the kinase JAK1 generates actomyosin contractility through Rho-kinase dependent signaling. This pathway generates contractile force in stromal fibroblasts to remodel the extracellular matrix to create tracks for collective migration of squamous carcinoma cells and provides the high levels of actomyosin contractility required for migration of individual melanoma cells in the rounded, "amoeboid" mode. Thus, cytokine signaling can generate actomyosin contractility in both stroma and tumor cells. Strikingly, actomyosin contractility itself positively modulates activity of the transcription factor STAT3 downstream of JAK1, demonstrating positive feedback within the signaling network.

Citing Articles

Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis.

Maiques O, Sallan M, Laddach R, Pandya P, Varela A, Crosas-Molist E Nat Commun. 2025; 16(1):1394.

PMID: 39952917 PMC: 11829002. DOI: 10.1038/s41467-025-56299-7.


Systemic Mechanisms of Ionic Regulation in Carcinogenesis.

Zamay T, Zamay S, Zamay G, Kolovskaya O, Kichkailo A, Berezovski M Cancers (Basel). 2025; 17(2).

PMID: 39858068 PMC: 11764231. DOI: 10.3390/cancers17020286.


Cancer-associated fibroblasts in carcinogenesis.

Zhou S, Zhao Z, Wang Z, Xu H, Li Y, Xu K J Transl Med. 2025; 23(1):50.

PMID: 39806363 PMC: 11727299. DOI: 10.1186/s12967-025-06071-8.


Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents.

Fouillet J, Torchio J, Rubira L, Fersing C Biology (Basel). 2025; 13(12.

PMID: 39765634 PMC: 11673949. DOI: 10.3390/biology13120967.


An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis.

Alqabandi J, David R, Abdel-Motal U, ElAbd R, Youcef-Toumi K Sci Rep. 2024; 14(1):30107.

PMID: 39627312 PMC: 11615046. DOI: 10.1038/s41598-024-79154-z.